ARCHIVES

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 7 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Of Smokers Screened With CT In Study, 7% Have Lung Cancer

December 31, 2004

DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects

July 4, 1986

Bush Keeps Klausner As NCI Director; Senate Confirms Thompson For HHS.

January 26, 2001

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012

RFA For Patient Compliance Study

September 26, 1980

In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him

August 4, 1978